Jules Bordet Institute
Clinical trials sponsored by Jules Bordet Institute, explained in plain language.
-
PET scan could personalize breast cancer treatment after drug failure
Disease control Recruiting nowThis study is for people with advanced HER2-positive breast cancer whose disease has worsened after treatment with trastuzumab deruxtecan (T-DXd). Researchers will use a special PET scan (HER2-PET/CT) to see if the cancer still has HER2 targets. If the scan is positive, participa…
Phase: PHASE2 • Sponsor: Jules Bordet Institute • Aim: Disease control
Last updated May 26, 2026 03:28 UTC
-
New radiation approach may offer better control for returning prostate cancer
Disease control Recruiting nowThis study tests whether a highly focused type of radiation (SBRT) can better manage prostate cancer that returns after the prostate is removed, compared to usual treatments. About 284 men with a rising PSA after surgery will be randomly assigned to receive SBRT or standard care.…
Phase: NA • Sponsor: Jules Bordet Institute • Aim: Disease control
Last updated May 26, 2026 03:26 UTC
-
New study aims to find best Pre-Surgery treatment for older rectal cancer patients
Disease control Recruiting nowThis study compares two standard treatment approaches given before surgery for older adults (70+) with locally advanced rectal cancer. The goal is to see which approach helps people live longer and with fewer side effects. About 230 participants will be randomly assigned to one o…
Phase: NA • Sponsor: Jules Bordet Institute • Aim: Disease control
Last updated May 26, 2026 03:10 UTC
-
Radiation boosts failing breast cancer drugs in new trial
Disease control Recruiting nowThis study tests whether precisely targeted radiation (SBRT) can extend the usefulness of current hormone therapy or CDK4/6 inhibitors in women with ER+/HER2- metastatic breast cancer that has started to progress in just 1-3 spots. Participants continue their existing medication …
Phase: NA • Sponsor: Jules Bordet Institute • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
Can testosterone boost well-being in end-of-life care?
Symptom relief Recruiting nowThis study tests whether giving testosterone every 15 days can improve quality of life in 20 men with low testosterone who are in palliative care and have no further treatment options. Participants receive injections of Sustanon 250 and complete questionnaires about symptoms and …
Phase: EARLY_PHASE1 • Sponsor: Jules Bordet Institute • Aim: Symptom relief
Last updated May 20, 2026 11:55 UTC
-
New study aims to uncover hidden hernia risks in aggressive cancer surgery
Knowledge-focused Recruiting nowThis study looks back at 500 patients who had extensive abdominal surgery for advanced cancers, sometimes with heated chemotherapy. The goal is to find out how often incisional hernias develop and what factors make them more likely. By identifying these risks, doctors hope to imp…
Sponsor: Jules Bordet Institute • Aim: Knowledge-focused
Last updated May 26, 2026 03:04 UTC
-
New study aims to predict prostate cancer treatment success early
Knowledge-focused Recruiting nowThis study looks at whether a special scan can predict if men with advanced prostate cancer will respond to a targeted radiation treatment. About 110 men will get the treatment and have scans to measure the radiation dose to their tumors. The goal is to see if the dose can tell e…
Sponsor: Jules Bordet Institute • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC
-
New research platform aims to unlock secrets of brain metastases
Knowledge-focused Recruiting nowThis study is for people with solid tumors that have spread to the brain. Researchers want to collect data and samples (like blood and spinal fluid) from 600 participants to understand why and how brain metastases happen. The goal is to find better ways to treat or prevent them i…
Phase: NA • Sponsor: Jules Bordet Institute • Aim: Knowledge-focused
Last updated May 07, 2026 18:42 UTC